Capital Markets Day: Commercial Execution and Innovation in Obesity Care

24 Commercial execution and innovation Obesity care The aspiration is now more than DKK 25 billion in sales by 2025 Strategic Aspiration of DKK billion 30 30 20 20 bDKK 10 8 6 >25 OK Obesity care sales by 2025 Note: The strategic aspirations are not a projection of Novo Nordisk's financial outlook or expected growth. 0 2019 2021 Novo Nordisk Obesity care sales >25 2025E Novo NordiskⓇ CMD22 CAPITAL MARKETS DAY

View entire presentation